Cahill Represents Lead Arrangers in $3.5 Billion Credit Facilities for QuidelOrtho Corporation
Cahill represented the lead arrangers in connection with a $2,750,000,000 term loan credit facility and a $750,000,000 revolving credit facility for QuidelOrtho Corporation. Proceeds from the credit facilities were used to (x) finance the business combination of Quidel Corporation and Ortho Clinical Diagnostics Holdings plc, (y) refinance existing debt and (z) pay fees, transaction costs and expenses related to the foregoing. Proceeds from the revolving credit facility may be used to provide ongoing working capital and for general corporate purposes. QuidelOrtho Corporation unites the power of Quidel Corporation, a leading manufacturer of diagnostic solutions at the point of care, and Ortho Clinical Diagnostics, one of the world’s larger pure-play in vitro diagnostics companies, behind a shared mission of developing and manufacturing innovative technologies that raise the performance of diagnostic testing and create better patient outcomes across the entire healthcare continuum.